Haha Boz, remeber we were seeing value here at 8c - 10c! Now 1.3c. You are right the CR's ruined the stock. But not the company. Could gain some serious traction from these levels.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%